{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:40:35Z","timestamp":1785894035726,"version":"3.56.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Centrally administered insulin-like growth factor (IGF)-I has anti-depressant activity in several rodent models, including lipopolysaccharide (LPS)-induced depression. In this study we tested the ability of IGF-I and GPE (the N-terminal tri-peptide derived from IGF-I) to alter depression-like behavior induced by intraperitoneal (i.p.) administration of LPS in a preventive and curative manner. In the first case, IGF-I (1 \u03bcg) or GPE (5 \u03bcg) was administered i.c.v. to CD-1 mice followed 30 min later by 330 \u03bcg\/kg body weight i.p. LPS. In the second case, 830 \u03bcg\/kg body weight LPS was given 24 h prior to either IGF-I or GPE. When administered i.p., LPS induced full-blown sickness assessed as a loss of body weight, decrease in food intake and sickness behavior. None of these indices were affected by IGF-I or GPE. LPS also induced depression-like behavior; assessed as an increased duration of immobility in the tail suspension and forced swim tests. When administered before or after LPS, IGF-I and GPE abrogated the LPS response; attenuating induction of depression-like behaviors and blocking preexistent depression-like behaviors. Similar to previous work with IGF-I, GPE decreased brain expression of cytokines in response to LPS although unlike IGF-I, GPE did not induce the expression of brain-derived neurotrophic factor (BDNF). LPS induced expression of tryptophan dioxygenases, IDO1, IDO2 and TDO2, but expression of these enzymes was not altered by GPE. Thus, both IGF-I and GPE elicit specific improvement in depression-like behavior independent of sickness, an action that could be due to their anti-inflammatory properties.<\/jats:p>","DOI":"10.1186\/1742-2094-8-179","type":"journal-article","created":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T19:36:37Z","timestamp":1324496197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide"],"prefix":"10.1186","volume":"8","author":[{"given":"Sook-Eun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dantzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith W","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H","family":"McCusker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,21]]},"reference":[{"key":"488_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","volume":"27","author":"CL Raison","year":"2006","unstructured":"Raison CL, Capuron L, Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27: 24-31. 10.1016\/j.it.2005.11.006.","journal-title":"Trends Immunol"},{"key":"488_CR2","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL: Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009, 65: 732-741. 10.1016\/j.biopsych.2008.11.029.","journal-title":"Biol Psychiatry"},{"key":"488_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW: From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008, 9: 46-56. 10.1038\/nrn2297.","journal-title":"Nat Rev Neurosci"},{"key":"488_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","volume":"58","author":"A Reichenberg","year":"2001","unstructured":"Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T: Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry. 2001, 58: 445-452. 10.1001\/archpsyc.58.5.445.","journal-title":"Arch Gen Psychiatry"},{"key":"488_CR5","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.biopsych.2010.06.010","volume":"68","author":"NI Eisenberger","year":"2010","unstructured":"Eisenberger NI, Berkman ET, Inagaki TK, Rameson LT, Mashal NM, Irwin MR: Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry. 2010, 68: 748-754. 10.1016\/j.biopsych.2010.06.010.","journal-title":"Biol Psychiatry"},{"key":"488_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.biopsych.2009.03.015","volume":"66","author":"NA Harrison","year":"2009","unstructured":"Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD: Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry. 2009, 66: 407-414. 10.1016\/j.biopsych.2009.03.015.","journal-title":"Biol Psychiatry"},{"issue":"Suppl 1","key":"488_CR7","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/S0889-1591(02)00078-8","volume":"17","author":"L Capuron","year":"2003","unstructured":"Capuron L, Dantzer R: Cytokines and depression: the need for a new paradigm. Brain Behav Immun. 2003, 17 (Suppl 1): S119-124.","journal-title":"Brain Behav Immun"},{"key":"488_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","volume":"26","author":"L Capuron","year":"2002","unstructured":"Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, Miller AH: Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology. 2002, 26: 643-652. 10.1016\/S0893-133X(01)00407-9.","journal-title":"Neuropsychopharmacology"},{"key":"488_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(95)01415-2","volume":"711","author":"R Yirmiya","year":"1996","unstructured":"Yirmiya R: Endotoxin produces a depressive-like episode in rats. Brain Res. 1996, 711: 163-174. 10.1016\/0006-8993(95)01415-2.","journal-title":"Brain Res"},{"key":"488_CR10","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.psyneuen.2007.03.005","volume":"32","author":"F Frenois","year":"2007","unstructured":"Frenois F, Moreau M, O'Connor J, Lawson M, Micon C, Lestage J, Kelley KW, Dantzer R, Castanon N: Lipopolysaccharide induces delayed FosB\/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology. 2007, 32: 516-531. 10.1016\/j.psyneuen.2007.03.005.","journal-title":"Psychoneuroendocrinology"},{"key":"488_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1742-2094-8-12","volume":"8","author":"SE Park","year":"2011","unstructured":"Park SE, Dantzer R, Kelley KW, McCusker RH: Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice. J Neuroinflammation. 2011, 8: 12-10.1186\/1742-2094-8-12.","journal-title":"J Neuroinflammation"},{"key":"488_CR12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0893-133X(00)00226-8","volume":"24","author":"R Yirmiya","year":"2001","unstructured":"Yirmiya R, Pollak Y, Barak O, Avitsur R, Ovadia H, Bette M, Weihe E, Weidenfeld J: Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology. 2001, 24: 531-544. 10.1016\/S0893-133X(00)00226-8.","journal-title":"Neuropsychopharmacology"},{"key":"488_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","volume":"14","author":"JC O'Connor","year":"2009","unstructured":"O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R: Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry. 2009, 14: 511-522. 10.1038\/sj.mp.4002148.","journal-title":"Mol Psychiatry"},{"key":"488_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1742-2094-5-15","volume":"5","author":"CJ Henry","year":"2008","unstructured":"Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT, Sheridan JF, Godbout JP: Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation. 2008, 5: 15-10.1186\/1742-2094-5-15.","journal-title":"J Neuroinflammation"},{"key":"488_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bbi.2010.11.008","volume":"25","author":"J Gibb","year":"2011","unstructured":"Gibb J, Hayley S, Poulter MO, Anisman H: Effects of stressors and immune activating agents on peripheral and central cytokines in mouse strains that differ in stressor responsivity. Brain Behav Immun. 2011, 25: 468-482. 10.1016\/j.bbi.2010.11.008.","journal-title":"Brain Behav Immun"},{"key":"488_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbr.2011.03.060","volume":"222","author":"C Bay-Richter","year":"2011","unstructured":"Bay-Richter C, Janelidze S, Hallberg L, Brundin L: Changes in behaviour and cytokine expression upon a peripheral immune challenge. Behav Brain Res. 2011, 222: 193-199. 10.1016\/j.bbr.2011.03.060.","journal-title":"Behav Brain Res"},{"key":"488_CR17","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/79871","volume":"3","author":"AR Damasio","year":"2000","unstructured":"Damasio AR, Grabowski TJ, Bechara A, Damasio H, Ponto LL, Parvizi J, Hichwa RD: Subcortical and cortical brain activity during the feeling of self-generated emotions. Nat Neurosci. 2000, 3: 1049-1056. 10.1038\/79871.","journal-title":"Nat Neurosci"},{"key":"488_CR18","doi-asserted-by":"publisher","first-page":"11818","DOI":"10.1073\/pnas.191355898","volume":"98","author":"AJ Blood","year":"2001","unstructured":"Blood AJ, Zatorre RJ: Intensely pleasurable responses to music correlate with activity in brain regions implicated in reward and emotion. Proc Natl Acad Sci USA. 2001, 98: 11818-11823. 10.1073\/pnas.191355898.","journal-title":"Proc Natl Acad Sci USA"},{"key":"488_CR19","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/cercor\/13.10.1064","volume":"13","author":"ML Kringelbach","year":"2003","unstructured":"Kringelbach ML, O'Doherty J, Rolls ET, Andrews C: Activation of the human orbitofrontal cortex to a liquid food stimulus is correlated with its subjective pleasantness. Cereb Cortex. 2003, 13: 1064-1071. 10.1093\/cercor\/13.10.1064.","journal-title":"Cereb Cortex"},{"key":"488_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.biopsycho.2004.03.004","volume":"67","author":"JB Nitschke","year":"2004","unstructured":"Nitschke JB, Heller W, Etienne MA, Miller GA: Prefrontal cortex activity differentiates processes affecting memory in depression. Biol Psychol. 2004, 67: 125-143. 10.1016\/j.biopsycho.2004.03.004.","journal-title":"Biol Psychol"},{"key":"488_CR21","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbr.2007.03.010","volume":"182","author":"J Burgdorf","year":"2007","unstructured":"Burgdorf J, Wood PL, Kroes RA, Moskal JR, Panksepp J: Neurobiology of 50-kHz ultrasonic vocalizations in rats: electrode mapping, lesion, and pharmacology studies. Behav Brain Res. 2007, 182: 274-283. 10.1016\/j.bbr.2007.03.010.","journal-title":"Behav Brain Res"},{"key":"488_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/0031-9384(94)90285-2","volume":"56","author":"J Panksepp","year":"1994","unstructured":"Panksepp J, Normansell L, Cox JF, Siviy SM: Effects of neonatal decortication on the social play of juvenile rats. Physiol Behav. 1994, 56: 429-443. 10.1016\/0031-9384(94)90285-2.","journal-title":"Physiol Behav"},{"key":"488_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neulet.2010.07.084","volume":"484","author":"GE Hodes","year":"2010","unstructured":"Hodes GE, Hill-Smith TE, Lucki I: Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female mice. Neurosci Lett. 2010, 484: 12-16. 10.1016\/j.neulet.2010.07.084.","journal-title":"Neurosci Lett"},{"key":"488_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1100\/tsw.2006.22","volume":"6","author":"ND Aberg","year":"2006","unstructured":"Aberg ND, Brywe KG, Isgaard J: Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. ScientificWorldJournal. 2006, 6: 53-80.","journal-title":"ScientificWorldJournal"},{"key":"488_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1385\/MN:27:2:153","volume":"27","author":"E Carro","year":"2003","unstructured":"Carro E, Trejo JL, Nunez A, Torres-Aleman I: Brain repair and neuroprotection by serum insulin-like growth factor I. Mol Neurobiol. 2003, 27: 153-162. 10.1385\/MN:27:2:153.","journal-title":"Mol Neurobiol"},{"key":"488_CR26","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1073\/pnas.83.13.4904","volume":"83","author":"VR Sara","year":"1986","unstructured":"Sara VR, Carlsson-Skwirut C, Andersson C, Hall E, Sjogren B, Holmgren A, Jornvall H: Characterization of somatomedins from human fetal brain: identification of a variant form of insulin-like growth factor I. Proc Natl Acad Sci USA. 1986, 83: 4904-4907. 10.1073\/pnas.83.13.4904.","journal-title":"Proc Natl Acad Sci USA"},{"key":"488_CR27","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/j.1476-5381.2009.00256.x","volume":"157","author":"J Guan","year":"2009","unstructured":"Guan J, Gluckman PD: IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions. Br J Pharmacol. 2009, 157: 881-891. 10.1111\/j.1476-5381.2009.00256.x.","journal-title":"Br J Pharmacol"},{"key":"488_CR28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/1357-2725(96)00056-8","volume":"28","author":"FJ Ballard","year":"1996","unstructured":"Ballard FJ, Wallace JC, Francis GL, Read LC, Tomas FM: Des(1-3)IGF-I: a truncated form of insulin-like growth factor-I. Int J Biochem Cell Biol. 1996, 28: 1085-1087. 10.1016\/1357-2725(96)00056-8.","journal-title":"Int J Biochem Cell Biol"},{"key":"488_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/0014-5793(86)80568-3","volume":"201","author":"C Carlsson-Skwirut","year":"1986","unstructured":"Carlsson-Skwirut C, Jornvall H, Holmgren A, Andersson C, Bergman T, Lundquist G, Sjogren B, Sara VR: Isolation and characterization of variant IGF-1 as well as IGF-2 from adult human brain. FEBS Lett. 1986, 201: 46-50. 10.1016\/0014-5793(86)80568-3.","journal-title":"FEBS Lett"},{"key":"488_CR30","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.neuropharm.2004.07.002","volume":"47","author":"J Guan","year":"2004","unstructured":"Guan J, Thomas GB, Lin H, Mathai S, Bachelor DC, George S, Gluckman PD: Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic-ischemic adult rats. Neuropharmacology. 2004, 47: 892-903. 10.1016\/j.neuropharm.2004.07.002.","journal-title":"Neuropharmacology"},{"key":"488_CR31","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1210\/en.135.6.2432","volume":"135","author":"H Yamamoto","year":"1994","unstructured":"Yamamoto H, Murphy LJ: Generation of des-(1-3) insulin-like growth factor-I in serum by an acid protease. Endocrinology. 1994, 135: 2432-2439. 10.1210\/en.135.6.2432.","journal-title":"Endocrinology"},{"key":"488_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1677\/joe.0.1460141","volume":"146","author":"H Yamamoto","year":"1995","unstructured":"Yamamoto H, Murphy LJ: Enzymatic conversion of IGF-I to des(1-3)IGF-I in rat serum and tissues: a further potential site of growth hormone regulation of IGF-I action. J Endocrinol. 1995, 146: 141-148. 10.1677\/joe.0.1460141.","journal-title":"J Endocrinol"},{"key":"488_CR33","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1210\/en.134.3.1589","volume":"134","author":"JP Bourguignon","year":"1994","unstructured":"Bourguignon JP, Alvarez Gonzalez ML, Gerard A, Franchimont P: Gonadotropin releasing hormone inhibitory autofeedback by subproducts antagonist at N-methyl-D-aspartate receptors: a model of autocrine regulation of peptide secretion. Endocrinology. 1994, 134: 1589-1592. 10.1210\/en.134.3.1589.","journal-title":"Endocrinology"},{"key":"488_CR34","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1159\/000126586","volume":"58","author":"JP Bourguignon","year":"1993","unstructured":"Bourguignon JP, Gerard A, Alvarez Gonzalez ML, Franchimont P: Acute suppression of gonadotropin-releasing hormone secretion by insulin-like growth factor I and subproducts: an age-dependent endocrine effect. Neuroendocrinology. 1993, 58: 525-530. 10.1159\/000126586.","journal-title":"Neuroendocrinology"},{"key":"488_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S0006-8993(00)01988-0","volume":"859","author":"J Guan","year":"2000","unstructured":"Guan J, Krishnamurthi R, Waldvogel HJ, Faull RL, Clark R, Gluckman P: N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Res. 2000, 859: 286-292. 10.1016\/S0006-8993(00)01988-0.","journal-title":"Brain Res"},{"key":"488_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0006-8993(01)03148-1","volume":"922","author":"SV Sizonenko","year":"2001","unstructured":"Sizonenko SV, Sirimanne ES, Williams CE, Gluckman PD: Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic-ischemic injury. Brain Res. 2001, 922: 42-50. 10.1016\/S0006-8993(01)03148-1.","journal-title":"Brain Res"},{"key":"488_CR37","volume-title":"The Mouse Brain in Stereotaxic Coordinates, Deluxe Edition of the Atlas","author":"G Paxinos","year":"2001","unstructured":"Paxinos G, Franklin KBJ: The Mouse Brain in Stereotaxic Coordinates, Deluxe Edition of the Atlas. 2001, London: Academic Press, Second","edition":"Second"},{"key":"488_CR38","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/glia.20947","volume":"58","author":"AI Rojo","year":"2010","unstructured":"Rojo AI, Innamorato NG, Martin-Moreno AM, De Ceballos ML, Yamamoto M, Cuadrado A: Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. Glia. 2010, 58: 588-598.","journal-title":"Glia"},{"key":"488_CR39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.mcn.2007.10.016","volume":"37","author":"JL Trejo","year":"2008","unstructured":"Trejo JL, Llorens-Martin MV, Torres-Aleman I: The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis. Mol Cell Neurosci. 2008, 37: 402-411. 10.1016\/j.mcn.2007.10.016.","journal-title":"Mol Cell Neurosci"},{"key":"488_CR40","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.bbr.2008.11.016","volume":"198","author":"CH Duman","year":"2009","unstructured":"Duman CH, Schlesinger L, Terwilliger R, Russell DS, Newton SS, Duman RS: Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise. Behav Brain Res. 2009, 198: 366-371. 10.1016\/j.bbr.2008.11.016.","journal-title":"Behav Brain Res"},{"key":"488_CR41","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.neuroscience.2010.03.045","volume":"168","author":"J Burgdorf","year":"2010","unstructured":"Burgdorf J, Kroes RA, Beinfeld MC, Panksepp J, Moskal JR: Uncovering the molecular basis of positive affect using rough-and-tumble play in rats: a role for insulin-like growth factor I. Neuroscience. 2010, 168: 769-777. 10.1016\/j.neuroscience.2010.03.045.","journal-title":"Neuroscience"},{"key":"488_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.brainres.2005.01.007","volume":"1037","author":"BA Hoshaw","year":"2005","unstructured":"Hoshaw BA, Malberg JE, Lucki I: Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res. 2005, 1037: 204-208. 10.1016\/j.brainres.2005.01.007.","journal-title":"Brain Res"},{"key":"488_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejphar.2008.07.023","volume":"594","author":"BA Hoshaw","year":"2008","unstructured":"Hoshaw BA, Hill TI, Crowley JJ, Malberg JE, Khawaja X, Rosenzweig-Lipson S, Schechter LE, Lucki I: Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission. Eur J Pharmacol. 2008, 594: 109-116. 10.1016\/j.ejphar.2008.07.023.","journal-title":"Eur J Pharmacol"},{"key":"488_CR44","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1038\/sj.npp.1301358","volume":"32","author":"JE Malberg","year":"2007","unstructured":"Malberg JE, Platt B, Rizzo SJ, Ring RH, Lucki I, Schechter LE, Rosenzweig-Lipson S: Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effects. Neuropsychopharmacology. 2007, 32: 2360-2368. 10.1038\/sj.npp.1301358.","journal-title":"Neuropsychopharmacology"},{"key":"488_CR45","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0006-291X(89)80032-4","volume":"165","author":"VR Sara","year":"1989","unstructured":"Sara VR, Carlsson-Skwirut C, Bergman T, Jornvall H, Roberts PJ, Crawford M, Hakansson LN, Civalero I, Nordberg A: Identification of Gly-Pro-Glu (GPE), the aminoterminal tripeptide of insulin-like growth factor 1 which is truncated in brain, as a novel neuroactive peptide. Biochem Biophys Res Commun. 1989, 165: 766-771. 10.1016\/S0006-291X(89)80032-4.","journal-title":"Biochem Biophys Res Commun"},{"key":"488_CR46","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1749-6632.2001.tb05827.x","volume":"933","author":"R Dantzer","year":"2001","unstructured":"Dantzer R: Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci. 2001, 933: 222-234.","journal-title":"Ann N Y Acad Sci"},{"key":"488_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00702-008-0159-8","volume":"116","author":"EE Aliaga","year":"2009","unstructured":"Aliaga EE, Mendoza I, Tapia-Arancibia L: Distinct subcellular localization of BDNF transcripts in cultured hypothalamic neurons and modification by neuronal activation. J Neural Transm. 2009, 116: 23-32. 10.1007\/s00702-008-0159-8.","journal-title":"J Neural Transm"},{"key":"488_CR48","volume-title":"Genes Brain Behav","author":"K Sakata","year":"2010","unstructured":"Sakata K, Jin L, Jha S: Lack of promoter IV-driven BDNF transcription results in depression-like behavior. Genes Brain Behav. 2010"},{"key":"488_CR49","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/sj.npp.1301360","volume":"32","author":"F Calabrese","year":"2007","unstructured":"Calabrese F, Molteni R, Maj PF, Cattaneo A, Gennarelli M, Racagni G, Riva MA: Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology. 2007, 32: 2351-2359. 10.1038\/sj.npp.1301360.","journal-title":"Neuropsychopharmacology"},{"key":"488_CR50","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0006-8993(99)02051-X","volume":"847","author":"J Bourguignon","year":"1999","unstructured":"Bourguignon J, Gerard A: Role of insulin-like growth factor binding proteins in limitation of IGF-I degradation into the N-methyl-D-aspartate receptor antagonist GPE: evidence from gonadotrophin-releasing hormone secretion in vitro at two developmental stages. Brain Res. 1999, 847: 247-252. 10.1016\/S0006-8993(99)02051-X.","journal-title":"Brain Res"},{"key":"488_CR51","first-page":"1111","volume":"4","author":"L Nilsson-Hakansson","year":"1993","unstructured":"Nilsson-Hakansson L, Civalero I, Zhang X, Carlsson-Skwirut C, Sara VR, Nordberg A: Effects of IGF-1, truncated IGF-1 and the tripeptide Gly-Pro-Glu on acetylcholine release from parietal cortex of rat brain. Neuroreport. 1993, 4: 1111-1114.","journal-title":"Neuroreport"},{"key":"488_CR52","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1016\/j.bmcl.2006.04.033","volume":"16","author":"SA Alonso De Diego","year":"2006","unstructured":"Alonso De Diego SA, Gutierrez-Rodriguez M, Perez de Vega MJ, Gonzalez-Muniz R, Herranz R, Martin-Martinez M, Cenarruzabeitia E, Frechilla D, Del Rio J, Jimeno ML, Garcia-Lopez MT: The neuroprotective activity of GPE tripeptide analogues does not correlate with glutamate receptor binding affinity. Bioorg Med Chem Lett. 2006, 16: 3396-3400. 10.1016\/j.bmcl.2006.04.033.","journal-title":"Bioorg Med Chem Lett"},{"key":"488_CR53","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1097\/00001756-200410050-00022","volume":"15","author":"C Escartin","year":"2004","unstructured":"Escartin C, Boyer F, Bemelmans AP, Hantraye P, Brouillet E: Insulin growth factor-1 protects against excitotoxicity in the rat striatum. Neuroreport. 2004, 15: 2251-2254. 10.1097\/00001756-200410050-00022.","journal-title":"Neuroreport"},{"key":"488_CR54","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1006\/exnr.1999.7168","volume":"159","author":"T Alexi","year":"1999","unstructured":"Alexi T, Hughes PE, van Roon-Mom WM, Faull RL, Williams CE, Clark RG, Gluckman PD: The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease. Exp Neurol. 1999, 159: 84-97. 10.1006\/exnr.1999.7168.","journal-title":"Exp Neurol"},{"key":"488_CR55","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","volume":"36","author":"R Dantzer","year":"2011","unstructured":"Dantzer R, O'Connor JC, Lawson MA, Kelley KW: Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology. 2011, 36: 426-436. 10.1016\/j.psyneuen.2010.09.012.","journal-title":"Psychoneuroendocrinology"},{"key":"488_CR56","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0889-1591(02)00014-4","volume":"16","author":"J Lestage","year":"2002","unstructured":"Lestage J, Verrier D, Palin K, Dantzer R: The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav Immun. 2002, 16: 596-601. 10.1016\/S0889-1591(02)00014-4.","journal-title":"Brain Behav Immun"},{"key":"488_CR57","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R: The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 702-721. 10.1016\/j.pnpbp.2010.12.017.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"488_CR58","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.biocel.2008.01.005","volume":"41","author":"HJ Ball","year":"2009","unstructured":"Ball HJ, Yuasa HJ, Austin CJ, Weiser S, Hunt NH: Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol. 2009, 41: 467-471. 10.1016\/j.biocel.2008.01.005.","journal-title":"Int J Biochem Cell Biol"},{"key":"488_CR59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1600-0897.2010.00820.x","volume":"64","author":"H Nishizawa","year":"2010","unstructured":"Nishizawa H, Kato T, Ota S, Nishiyama S, Pryor-Koishi K, Suzuki M, Tsutsumi M, Inagaki H, Kurahashi H, Udagawa Y: Genetic variation in the indoleamine 2,3-dioxygenase gene in pre-eclampsia. Am J Reprod Immunol. 2010, 64: 68-76.","journal-title":"Am J Reprod Immunol"},{"key":"488_CR60","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1523\/JNEUROSCI.22-10-04153.2002","volume":"22","author":"S Akbarian","year":"2002","unstructured":"Akbarian S, Rios M, Liu RJ, Gold SJ, Fong HF, Zeiler S, Coppola V, Tessarollo L, Jones KR, Nestler EJ, et al: Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons. J Neurosci. 2002, 22: 4153-4162.","journal-title":"J Neurosci"},{"key":"488_CR61","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.coph.2006.08.009","volume":"7","author":"E Castren","year":"2007","unstructured":"Castren E, Voikar V, Rantamaki T: Role of neurotrophic factors in depression. Curr Opin Pharmacol. 2007, 7: 18-21. 10.1016\/j.coph.2006.08.009.","journal-title":"Curr Opin Pharmacol"},{"key":"488_CR62","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/dneu.20758","volume":"70","author":"E Castren","year":"2010","unstructured":"Castren E, Rantamaki T: The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol. 2010, 70: 289-297. 10.1002\/dneu.20758.","journal-title":"Dev Neurobiol"},{"key":"488_CR63","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/187152409788452108","volume":"9","author":"O Bibollet-Bahena","year":"2009","unstructured":"Bibollet-Bahena O, Cui QL, Almazan G: The insulin-like growth factor-1 axis and its potential as a therapeutic target in central nervous system (CNS) disorders. Cent Nerv Syst Agents Med Chem. 2009, 9: 95-109.","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"488_CR64","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/dneu.20778","volume":"70","author":"I Torres-Aleman","year":"2010","unstructured":"Torres-Aleman I: Toward a comprehensive neurobiology of IGF-I. Dev Neurobiol. 2010, 70: 384-396.","journal-title":"Dev Neurobiol"},{"key":"488_CR65","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1755-5949.2009.00128.x","volume":"17","author":"J Guan","year":"2011","unstructured":"Guan J: Insulin-Like Growth Factor -1 (IGF-1) Derived Neuropeptides, a Novel Strategy for the Development of Pharmaceuticals for Managing Ischemic Brain Injury. CNS Neurosci Ther. 2011, 17: 250-255. 10.1111\/j.1755-5949.2009.00128.x.","journal-title":"CNS Neurosci Ther"},{"key":"488_CR66","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1677\/joe.0.1820445","volume":"182","author":"CM Reijnders","year":"2004","unstructured":"Reijnders CM, Koster JG, van Buul-Offers SC: Overexpression of human IGF-II mRNA in the brain of transgenic mice modulates IGFBP-2 gene expression in the medulla oblongata. J Endocrinol. 2004, 182: 445-455. 10.1677\/joe.0.1820445.","journal-title":"J Endocrinol"},{"key":"488_CR67","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0006-8993(98)00645-3","volume":"804","author":"MM Niblock","year":"1998","unstructured":"Niblock MM, Brunso-Bechtold JK, Lynch CD, Ingram RL, McShane T, Sonntag WE: Distribution and levels of insulin-like growth factor I mRNA across the life span in the Brown Norway x Fischer 344 rat brain. Brain Res. 1998, 804: 79-86. 10.1016\/S0006-8993(98)00645-3.","journal-title":"Brain Res"},{"key":"488_CR68","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/exnr.1999.7189","volume":"159","author":"X Zhou","year":"1999","unstructured":"Zhou X, Herman JP, Paden CM: Evidence that IGF-I acts as an autocrine\/paracrine growth factor in the magnocellular neurosecretory system: neuronal synthesis and induction of axonal sprouting. Exp Neurol. 1999, 159: 419-432. 10.1006\/exnr.1999.7189.","journal-title":"Exp Neurol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-8-179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T04:29:47Z","timestamp":1713241787000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-8-179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["488"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-8-179","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"25 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"179"}}